Clinical trial
Biodistribution and Safety of a Radiopharmaceutical in Healthy Subjects
NCT00316797 · Institute for Neurodegenerative Disorders, Other · Completed
Key facts
| NCT number | NCT00316797 |
|---|---|
| Title | Biodistribution and Safety of a Radiopharmaceutical in Healthy Subjects |
| Official title | Phase 1 Assessment of the Biodistribution and Safety of 123-I INER in Healthy Subjects |
| Lead sponsor | Institute for Neurodegenerative Disorders, Other |
| Collaborators | Molecular NeuroImaging |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neurodegenerative Diseases |
| Intervention type | Drug |
| Interventions | 123-I INER |
| Enrollment | 35 |
| Start date | Apr 1, 2006 |
| Primary completion | Dec 1, 2013 |
| Completion | Jan 1, 2014 |
| First posted | Apr 21, 2006 |
| Last update posted | Apr 10, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: